NINDS announces its intent to issue Funding Opportunity Announcements to support analytical validation of identified candidate biomarkers.
NINDS has renewed an initiative to provide set-aside funds for basic research grants that miss their regular payline.
NIH announces intent to reissue a Funding Opportunity Announcement for the Rare Disease Clinical Research Network competition.
Increased skin cancer risks in DM1 are captured in a new, longitudinal electronic medical records study.
A recent publication suggests that a serum protein may ultimately have value as a biomarker for conduction system abnormalities in DM.